Jaysynth Orgochem Ltd vs Tatva Chintan Pharma Chem Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 18, 2026

Key Highlights

The Latest Trading Price of Jaysynth Orgochem Ltd is ₹ 12.17 as of 18 Mar 15:30 . The P/E Ratio of Jaysynth Orgochem Ltd changed from 72.3 on March 2023 to 0 on March 2022 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Tatva Chintan Pharma Chem Ltd changed from 81.2 on March 2023 to 53.4 on March 2022 . This represents a CAGR of -8.04% over 5 years The Market Cap of Jaysynth Orgochem Ltd changed from ₹ 5.75 crore on March 2023 to ₹ 0 crore on March 2022 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Tatva Chintan Pharma Chem Ltd changed from ₹ 3694 crore on March 2023 to ₹ 5115 crore on March 2022 . This represents a CAGR of 6.72% over 5 years The revenue of Jaysynth Orgochem Ltd for the Dec '25 is ₹ 65.94 crore as compare to the Sep '25 revenue of ₹ 67.38 crore. This represent the decline of -2.14% The revenue of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 133.07 crore as compare to the Sep '25 revenue of ₹ 124.52 crore. This represent the growth of 6.87% The ebitda of Jaysynth Orgochem Ltd for the Dec '25 is ₹ 4.44 crore as compare to the Sep '25 ebitda of ₹ 7.96 crore. This represent the decline of -44.22% The ebitda of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 27.22 crore as compare to the Sep '25 ebitda of ₹ 23.22 crore. This represent the growth of 17.23% The net profit of Jaysynth Orgochem Ltd changed from ₹ 2.86 crore to ₹ 2.33 crore over 7 quarters. This represents a CAGR of -11.05% The net profit of Tatva Chintan Pharma Chem Ltd changed from ₹ 5.21 crore to ₹ 15.17 crore over 7 quarters. This represents a CAGR of 84.17% The Dividend Payout of Jaysynth Orgochem Ltd changed from 5.43 % on March 2024 to 4.24 % on March 2025 . This represents a CAGR of -11.63% over 2 yearsThe Dividend Payout of Tatva Chintan Pharma Chem Ltd changed from 19.56 % on March 2021 to 708.79 % on March 2025 . This represents a CAGR of 105.04% over 5 years .

About Jaysynth Orgochem Ltd

Jaysynth Orgochem Limited was initially incorporated as a private limited Company as 'Jaysynth Dyechem Private Limited' on October 5, 1973.
The Company got converted into a Public Limited Company and the name of the Company was changed from 'Jaysynth Dyechem Private Limited' to 'Jaysynth Dyechem Limited' and again from 'Jaysynth Dyechem Limited' to 'JD Orgochem Limited' vide Certificate of Incorporation dated 19 December, 2003.
The Company has attained a new change of name to 'Jaysynth Orgochem Limited' from 'JD Orgochem Limited' with effect from 03rd July, 2024. As reported, net worth of the Company was completely eroded as on March 31,2001 and the Company had become a Sick Industrial Unit.
The Company made reference to the Board for Industrial and Financial Re-construction (BIFR) u/s 15 of the said Act.

About Tatva Chintan Pharma Chem Ltd

Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996.
The status of the Company converted from Private Limited into a Public Limited Company from 27 January 2021 and the name of Company changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'.
The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is a globally recognized specialty chemical player with several market leading products in its portfolio.
The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i.e., Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC).

FAQs for the comparison of Jaysynth Orgochem Ltd and Tatva Chintan Pharma Chem Ltd

Which company has a larger market capitalization, Jaysynth Orgochem Ltd or Tatva Chintan Pharma Chem Ltd?

Market cap of Jaysynth Orgochem Ltd is 164 Cr while Market cap of Tatva Chintan Pharma Chem Ltd is 2,766 Cr

What are the key factors driving the stock performance of Jaysynth Orgochem Ltd and Tatva Chintan Pharma Chem Ltd?

The stock performance of Jaysynth Orgochem Ltd and Tatva Chintan Pharma Chem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Jaysynth Orgochem Ltd and Tatva Chintan Pharma Chem Ltd?

As of March 18, 2026, the Jaysynth Orgochem Ltd stock price is INR ₹12.17. On the other hand, Tatva Chintan Pharma Chem Ltd stock price is INR ₹1182.85.

How do dividend payouts of Jaysynth Orgochem Ltd and Tatva Chintan Pharma Chem Ltd compare?

To compare the dividend payouts of Jaysynth Orgochem Ltd and Tatva Chintan Pharma Chem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.